AbbVie
ABBV
#27
Rank
โ‚น32.268 T
Marketcap
โ‚น18,279
Share price
1.96%
Change (1 day)
23.86%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2024 (TTM): โ‚น305.05 Billion

According to AbbVie's latest financial reports the company's current earnings are โ‚น56.33 Billion. a decrease over its 2023 earnings that were of โ‚น546.54 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2024

Annual earnings

Year Earnings Change
2024 โ‚น324.95 B-40.54%
2023 โ‚น546.54 B-53.62%
2022 โ‚น1.178 T3.76%
2021 โ‚น1.135 T282.25%
2020 โ‚น297.14 B-59.67%
2019 โ‚น736.82 B62.13%
2018 โ‚น454.46 B-32.74%
2017 โ‚น675.70 B-1.99%
2016 โ‚น689.43 B18.65%
2015 โ‚น581.08 B180.5%
2014 โ‚น207.16 B-55.57%
2013 โ‚น466.26 B-6.86%
2012 โ‚น500.62 B56.05%
2011 โ‚น320.80 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น607.14 B 86.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น732.72 Billion-325.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.108 T 241.24%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น403.04 B 24.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น15.39 B-95.26%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น166.67 B-48.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น364.73 B 12.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น912.33 B 180.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น44.88 B-86.19%๐Ÿ‡บ๐Ÿ‡ธ USA